Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Breast Cancer × ribociclib × Clear all

Sponsor

Conditions

Breast Neoplasms 17 Melanoma 3 Glioma 3 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 2 Diffuse Intrinsic Pontine Glioma 2 Thymus Neoplasms 1 Teratoma 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Osteitis Deformans 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Mesothelioma 1 Medulloblastoma 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Glioblastoma 1 Familial ependymoma 1 Fallopian Tube Neoplasms 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Cystadenocarcinoma, Serous 1 Carcinoma, Hepatocellular 1

Interventions

Fulvestrant 3 Docetaxel 2 Dasatinib 2 vandetanib 1 sonidegib 1 pembrolizumab 1 palbociclib 1 olaparib 1 exemestane 1 cediranib 1 Letrozole 1 Goserelin 1 Gemcitabine 1 Everolimus 1 Capecitabine 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡